【上海医药:拟收购上海和黄药业10%股权】上海医药公告,公司计划联合上海金浦健服股权投资管理有限公司指定主体,收购和黄医药持有的上海和黄药业股权。上海医药拟以自有资金人民币9.95亿元收购其中的10%股权。交易完成后,上海医药将合计持有上海和黄药业60%股权,并对其实施并表。此次交易不构成《上市公司重大资产重组管理办法》规定的重大资产重组。

金融界
01 Jan
上海医药公告,公司计划联合上海金浦健服股权投资管理有限公司指定主体,收购和黄医药持有的上海和黄药业股权。上海医药拟以自有资金人民币9.95亿元收购其中的10%股权。交易完成后,上海医药将合计持有上海和黄药业60%股权,并对其实施并表。此次交易不构成《上市公司重大资产重组管理办法》规定的重大资产重组。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10